« Back

Update: Ocrelizumab

Fitted

Wednesday October 10 2018 10:33 AM

NCPE report

The National Centre for Pharmaco-economics (NCPE) have completed their evaluation of Ocrelizumab for the treatment of adult patients with early primary progressive Multiple Sclerosis (PPMS), and have sent the final report to the HSE CPU. The web summary is now available on the National Centre for Pharmacoeconomics website. >> Read more

The NCPE report recommends that ocrelizumab for the treatment of adult patients with early PPMS not be considered for reimbursement. 

MS Ireland have secured a meeting with the Minister for Health, Simon Harris on October 25th in relation to the issues of access to medicines. 

Related articles

Author: MS Ireland

Tags: accesstomedicines, ms, multiplesclerosis

Comments

Add a comment

Your email address will not be published and will only be used by MS Ireland to contact you should there be an issue with your comment.

Please read our policy on making comments. Basically, respect other people’s view, use appropriate language and be nice! Comments are published between 9am and 5pm, Monday to Friday.

We ask this question to ensure that you are a real person, and not a computer adding information automatically.

By commenting, you are adhering to our Terms of use / Privacy

Latest News

More news

What's hot

Job_opps

We're Hiring

If you would like to be part of our team, take a look at our current job opportunities.

Find out more

Events Calendar

» Our next Event

22 October 2018: Group led yoga class for people with MS and family/friends, starts 17th September.

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow